UK tribunal should have considered comparator products, Flynn argues
The UK’s Competition Appeal Tribunal was wrong not to consider drug distributor Flynn’s other products as comparators in its excessive pricing ruling despite overturning fines on the company, Flynn’s counsel have argued.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.